Multiple U.S. health agencies have released HIV-specific information, and research on HIV and the novel coronavirus is trickling in. Here's what health care providers need to know.
Recent Initiation of Testosterone Therapy Linked to Greater Atherosclerosis Progression in MSM With HIV
New findings contribute to the indication that people with HIV taking testosterone therapy should be counseled on the cardiovascular risks.
With Truvada going generic soon in the U.S., public health officials will need to make some decisions to make access to both drugs sustainable.
Addiction needs to be addressed by prevention and treatment, but policy makers need skin in the game too.
Taking more than five medications could be a problem. And many people with HIV are at risk of being on medication overload.
While there is not yet an app for helping patients to manage their fatigue, nurses can help patients get out of the house by finding a physical activity they enjoy.
Trauma-informed care should be implemented in all care settings, a study presented at the Association of Nurses in AIDS Care conference finds.
Amidst uncertainty regarding the safety of some integrase inhibitors during pregnancy, a study shows that an older integrase inhibitor may be a good option for those with HIV who intend to give birth.
People in jail, who are often in the system for less time than those in prison, often receive little to no hepatitis C screening or treatment. One provider works to change this in Massachusetts.
The question of whether INSTIs cause weight gain continues to be debated. This story draws together some research on which drugs are associated with weight gain or other metabolic changes.